Supriya Lifescience shareholders and shareholding pattern
NSE: SUPRIYABSE: 543434Pharmaceuticals & BiotechnologySmall Cap
Last close ₹818.55down ₹17.70 (2.12%)BSE ₹818.90
Share price at the NSE close on 23 Oct 2026. Previous close ₹836.25.
52-week range of traded prices to 23 Oct 2026
₹545.50Low, 24 Mar 2026₹1,085.00High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,588 Cr733rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 33.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 18.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 21.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,62,92342.0% delivered
Who owns Supriya Lifescience, filing by filing
Per cent of the company's shares. Every filing on record, from Dec 2021; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters68.30%
- Foreign institutions6.44%
- Indian institutions5.47%
- Individuals and others19.79%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2021Filed 13 Jan | Mar 2022Filed 13 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 17 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 14 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 9 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68.24% | 68.24% | 68.24% | 68.24% | 68.24% | 68.28% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | |
| Indian promoters | 68.24% | 68.24% | 68.24% | 68.24% | 68.24% | 68.28% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% | 68.30% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 31.76% | 31.76% | 31.76% | 31.76% | 31.76% | 31.72% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% | 31.70% |
| Shares in issue | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 | 8,04,82,800 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 6,64,31,706 | 5,49,35,355 | 5,49,35,355 | 5,49,20,715 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 0 | 0 | – | – | – | – | – | – |
| Promoters' shares locked in | 5,49,20,715 | 5,49,20,715 | 5,49,20,715 | 5,49,20,715 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 1,60,96,560 | 0 | 0 | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Supriya Lifescience promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Satish Waman Wagh, 67.64%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Satish Waman WaghIndividuals and Hindu undivided families | 67.64% | 5,44,41,205 |
| Smita Satish WaghIndividuals and Hindu undivided families | 0.40% | 3,21,750 |
| Saloni Satish WaghIndividuals and Hindu undivided families | 0.13% | 1,02,375 |
| Shivani Satish WaghIndividuals and Hindu undivided families | 0.13% | 1,02,375 |
| Satish Waman Wagh Partner representing SupriyaPharmaceuticalsIndian companies, trusts and others | 0.00% | 10 |
| Arun Waman WaghIndividuals and Hindu undivided families | 0.00% | 110 |
No promoter shares are reported as pledged.
Largest public holders of Supriya Lifescience, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Supriya Lifescience
| Holder | Dec 2021Filed 13 Jan | Mar 2022Filed 13 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 17 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 14 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 9 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 15 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 18 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COHESION MK BEST IDEAS SUB-TRUSTForeign portfolio investors, category II | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 1.99% | 2.06% | 2.06% | 2.13% | 2.13% | 2.54% | 2.98% | 2.98% | 3.17% |
| ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITEDInsurance companies | 1.01% | 1.12% | 3.89% | 3.56% | 3.56% | 3.64% | 3.65% | 3.68% | 3.60% | 3.50% | 3.61% | 3.02% | 2.27% | 1.49% | 2.11% | 2.15% | 2.11% | 2.14% | 2.19% | 2.16% |
| Hornbill Orchid India FundForeign portfolio investors, category I | 1.06% | 1.06% | 1.06% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | 1.89% | – | – | – | – | – |
| Dovetail India Fund Class 6 SharesForeign portfolio investors, category I | 1.85% | 1.81% | 1.81% | 1.81% | 1.81% | 1.13% | 1.13% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Malabar India Fund LimitedInstitutions Foreign Portfolio Investor | 1.36% | 1.36% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Kuber India FundInstitutions Foreign Portfolio Investor | 1.31% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.